|

high dose Rifampicin (RIF) Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • University of Cape Town1

Indications

  • HIV Status1
  • Tuberculous Pericarditis1
  • Heart Disease1

Other1 trial

High vs. Standard Dose Rifampicin for Effusive Tuberculous Pericarditis
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.